Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience
An. bras. dermatol
; 93(2): 299-301, Mar.-Apr. 2018. graf
Article
em En
| LILACS
| ID: biblio-1038267
Biblioteca responsável:
BR1.1
ABSTRACT
Abstract Diphencyprone has been reported as a local immunotherapy for cutaneous melanoma metastases. We aim to report cases of melanoma patients treated with diphencyprone in a single Brazilian institution and highlight their outcomes. Since 2012, we have treated 16 melanoma patients with cutaneous metastases with topical diphencyprone. To date, we have had 37.5% of complete response, 25% of partial responses, and 31.25% patients without any response. Treatment was well tolerated and local toxicity was easily controlled. We believe topical diphencyprone is a feasible treatment that can be another option for treating melanoma patients, especially in cases of in-transit or extensive disease.
Palavras-chave
Texto completo:
1
Base de dados:
LILACS
Assunto principal:
Neoplasias Cutâneas
/
Ciclopropanos
/
Melanoma
/
Antineoplásicos
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
País/Região como assunto:
America do sul
/
Brasil
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article